Placenta Accreta, Third Trimester Clinical Trial
Official title:
Gray-scale , Colour Doppler Ultrasound and Magnetic Resonance Imaging for Diagnosis of Placenta Accreta
This study aim to assess the accuracy of magnetic resonance imaging (MRI) compared to gray-scale and colour Doppler ultrasound (US) for the prenatal diagnosis of placenta accreta.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | January 2021 |
Est. primary completion date | January 2021 |
Accepts healthy volunteers | |
Gender | Female |
Age group | 20 Years to 40 Years |
Eligibility |
Inclusion Criteria: - Haemodynamically stable pregnant women who have the following risk factors for placenta accreta : persistent anterior placenta previa, prior uterine surgery (such as a previous cesarean section, uterine curettage, or myomectomy). - Maternal age : 20-40 years old. - BMI : 18-29.9 kg/m2. Exclusion Criteria: - Exclusion criteria will be MRI contraindications, cardiac pacemaker, metal objects in the body, and patient's refusal for MRI evaluation. - Haemodynamically unstable patients. |
Country | Name | City | State |
---|---|---|---|
Egypt | Faculty of medicine ainshams university | Cairo |
Lead Sponsor | Collaborator |
---|---|
Ain Shams University |
Egypt,
Haunschild C, Yeaton-Massey A, Lyell DJ. Antenatal Management of Placenta Accreta. Clin Obstet Gynecol. 2018 Dec;61(4):766-773. doi: 10.1097/GRF.0000000000000394. Review. — View Citation
Lopes ES, Feitosa FEL, Brazil AV, de Castro JDV, da Costa JIF, Araujo Júnior E, Peixoto AB, Carvalho FHC. Assessment of Sensitivity and Specificity of Ultrasound and Magnetic Resonance Imaging in the Diagnosis of Placenta Accreta. Rev Bras Ginecol Obstet. 2019 Jan;41(1):17-23. doi: 10.1055/s-0038-1675803. Epub 2018 Nov 14. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Determination of degree of placental invasion | Determination of degree of placental invasion by comparing the results obtained by ultrasound , MRI with the final pathological examination after operation ( the excised part of myometrium with the attached placenta or hysterectomy specimen ). | Baseline | |
Secondary | Change Maternal morbidity and mortality | Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05376410 -
Relationship Between Maternal Soluble Trigger Receptor Expressed on Myeloid Cells-1 (sTREM-1) and Placenta Accreta Spectrum
|
||
Not yet recruiting |
NCT05191316 -
the Efficacy and Safety of the 3-steps Conservative Approach in the Management of Placenta Accreta Spectrum (a Novel Technique)
|
||
Completed |
NCT05945446 -
A Serum Galectin-3 Levels in Placenta Accreta Spectrum Pregnancies
|
||
Recruiting |
NCT03947047 -
Detection of Placenta Accreta Via Exhaled Women Breath
|
||
Not yet recruiting |
NCT05513092 -
Placenta Accreta Index Score in Placenta Accreta Spectrum
|